OraSure Technologies (FRA:EP3) Growth Rank: 2 (As of Aug. 20, 2026) — 60% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EP3 OraSure Technologies Inc FRA:EP3
57 GF Score
Price €3.12
GF Value €1.77
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is OraSure Technologies Growth Rank?

OraSure Technologies FRA:EP3 -1.89% 57 Growth Rank is 2 as of Aug. 20, 2026, which is 60% below its 10-year median of 5.00. GuruFocus rates FRA:EP3 with a GF Score™ of 57/100 and a GF Value™ of €1.77 (Significantly Overvalued). The stock has 2 warning signs investors should review.

OraSure Technologies has the Growth Rank of 2.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

OraSure Technologies Growth Rank Related Terms

FRA:EP3 vs SMTI, UTMD, EMBC: Growth Rank Comparison

For the Medical Instruments & Supplies subindustry, OraSure Technologies's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OraSure Technologies Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Growth Rank distribution charts can be found below:

* The bar in red indicates where OraSure Technologies's Growth Rank falls into.


FRA:EP3
57GF Score
OraSure Technologies Inc FRA:EP3
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 2 mean?
OraSure Technologies (FRA:EP3) has a Growth Rank of 2 as of Aug. 20, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on OraSure Technologies and its competitors. This is 60% below median its historical median of 5.00. Over the past decade, OraSure Technologies' Growth Rank has ranged from 2.00 to 9.00.
Is OraSure Technologies' Growth Rank too high?
OraSure Technologies' current Growth Rank of 2 is 60% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 9.00. Overall, OraSure Technologies has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OraSure Technologies' Growth Rank compare to SMTI and UTMD?
OraSure Technologies' Growth Rank of 2 can be compared against companies in the Medical Devices & Instruments industry. Historically, OraSure Technologies' own Growth Rank has ranged from 2.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on OraSure Technologies and its competitors. OraSure Technologies's current Growth Rank is 2, which is 60% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OraSure Technologies stock overvalued right now?
Based on GuruFocus' analysis, OraSure Technologies (FRA:EP3) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.77, compared to a current price of €3.12 — trading 76.3% above its estimated fair value. The current Growth Rank is 2, which is 60% below median its 10-year median of 5.00. OraSure Technologies' overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For OraSure Technologies (FRA:EP3), the current Growth Rank is 2 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OraSure Technologies (FRA:EP3) Overvalued in 2026?

Based on GuruFocus' analysis, OraSure Technologies stock appears to be overvalued. The current stock price of €3.12 is trading 76.3% above its estimated GF Value™ of €1.77. GuruFocus considers OraSure Technologies to be Significantly Overvalued.

Key valuation signals for FRA:EP3:

  • Growth Rank: 2 (60% below median its 10-year median of 5.00)
  • GF Value™: €1.77 vs. price of €3.12 (76.3% above fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the FRA:EP3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OraSure Technologies Business Description

Other Exchanges OSUR:USA
Address 220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
57GF Score

Get the complete analysis for FRA:EP3

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.12
Price
€1.77
GF Value